查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1951829

生物防禦市場分析及預測（至2035年）：依類型、產品類型、服務、技術、組件、應用、最終用戶、功能、設備分類

Biodefense Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Functionality, Equipment
出版日期: | 出版商: Global Insight Services | 英文 324 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計生物防禦市場規模將從2024年的175億美元成長到2034年的351億美元，年複合成長率約為6.8%。生物防禦市場涵蓋旨在保護人民免受生物威脅（包括感染疾病和生物恐怖主義）的策略和技術，包括疫苗、診斷技術和用於預防、檢測和應對生物事件的檢測系統。日益嚴峻的全球健康威脅和各國政府的舉措正在推動生物防禦能力的進步，尤其注重快速反應和增強應對能力。

由於生物武器和感染疾病威脅日益加劇，生物防禦市場正經歷強勁成長。檢測領域取得了特別顯著的進展，先進的診斷系統和生物感測器在早期威脅識別中發揮關鍵作用。快速診斷試劑盒和攜帶式檢測設備因其高效性和易用性而備受關注。疫苗領域也緊隨其後，重組疫苗和合成疫苗的創新發展為抵禦新出現的病原體提供了更強的保護。治療領域（包括抗病毒藥物和單株抗體）也取得了重大進展，這反映了對有效治療方法的迫切需求。將人工智慧 (AI) 和機器學習融入生物防禦策略，提供預測性見解和簡化的應對機制，正變得日益重要。對研發的投資對於促進創新和確保應對潛在生物威脅的準備至關重要。政府機構和私營部門之間的合作對於加強全球生物防禦能力至關重要。

市場區隔
類型 疫苗、治療藥物、診斷試劑、檢測設備、監測系統、消毒液、防護設備和資訊技術
產品 炭疽菌、天花、肉毒桿菌中毒、輻射/核輻射、化學武器、伊波拉、茲卡
服務 諮詢、培訓、支援與維護、託管服務
科技 合成生物學、奈米科技、基因體學、生物資訊學
成分 硬體和軟體
應用 民事、軍事、緊急應變
最終用戶 政府、軍隊、私人公司、公共衛生機構
功能 偵測、保護、預防、回應和恢復
裝置 個人防護設備、偵測設備及去污設備

生物防禦市場的特點是眾多市場參與企業競相透過策略定價和創新產品推出爭取競爭優勢。全球意識的增強和對強大防禦機制的需求正推動企業開發先進的生物防禦解決方案。市場見證了成熟企業與新Start-Ups之間的動態互動，從而推動了市場環境的不斷演變。定價策略競爭激烈，反映了市場對兼具成本效益和先進技術的解決方案的需求。為了滿足政府和私營部門不斷變化的需求，新產品發布頻繁。生物防禦市場的競爭異常激烈，領導企業利用先進技術取得競爭優勢。區域法規結構對市場動態有顯著影響，嚴格的指導方針塑造產品開發和部署策略。公共和私營部門之間日益密切的合作正在推動創新和部署能力的提升。北美憑藉政府的大量投資保持主導地位，而亞太地區由於生物防禦措施的增加，正崛起為一個充滿潛力的市場。監管影響和競爭基準之間的相互作用持續決定市場走向，既帶來了挑戰，也帶來了成長機會。

主要趨勢和促進因素：

受生物威脅和流行病日益成長的擔憂推動，生物防禦市場正經歷強勁成長。主要趨勢包括各國政府加大對生物防禦基礎設施和研發的投資。各國優先開發快速診斷工具和疫苗，以因應生物恐怖主義和感染疾病疫情。旨在加強防範和應變能力的公私合營進一步推動了這一趨勢。市場促進因素包括病原體檢測和鑑定技術的進步。人工智慧 (AI) 和機器學習在生物防禦系統中的應用提高了威脅偵測的準確性和速度。此外，生物安全措施在醫療保健和農業領域的重要性日益凸顯，也推動了市場擴張。對先進生物防禦解決方案的需求，也因需要強大的監測系統來監測和減輕全球生物威脅而進一步成長。攜帶式且經濟高效的診斷工具的開發存在大量機遇，尤其是在新興國家。投資於創新生物技術解決方案的公司有望佔據可觀的市場佔有率。專注於開發下一代疫苗和療法將帶來盈利的成長前景。隨著全球對生物風險的認知不斷提高，在技術創新和戰略合作的推動下，生物防禦市場預計將繼續擴張。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 疫苗
    • 治療藥物
    • 診斷
    • 檢測裝置
    • 監控系統
    • 消毒液
    • 防護裝備
    • 資訊科技
  • 市場規模及預測：依產品分類
    • 炭疽菌
    • 天花
    • 肉毒桿菌中毒
    • 輻射/核能
    • 化學品
    • 伊波拉
    • 茲卡病毒
  • 市場規模及預測：依服務分類
    • 諮詢
    • 訓練
    • 支援與維護
    • 託管服務
  • 市場規模及預測：依技術分類
    • 合成生物學
    • 奈米科技
    • 基因組學
    • 生物資訊學
  • 市場規模及預測：依組件分類
    • 硬體
    • 軟體
  • 市場規模及預測：依應用領域分類
    • 私人的
    • 軍隊
    • 緊急應變
  • 市場規模及預測：依最終用戶分類
    • 政府
    • 軍隊
    • 私部門
    • 公共衛生機構
  • 市場規模及預測：依功能分類
    • 偵測
    • 保護
    • 預防
    • 一致
    • 恢復
  • 市場規模及預測：依設備分類
    • 個人防護設備
    • 檢測設備
    • 消毒設備

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Emergent Bio Solutions
  • Bavarian Nordic
  • Dyn Port Vaccine Company
  • SIGA Technologies
  • Elusys Therapeutics
  • Soligenix
  • Pharm Athene
  • Cangene Corporation
  • Alnylam Pharmaceuticals
  • Bio Factura
  • Achaogen
  • Inovio Pharmaceuticals
  • Chimerix
  • Nanotherapeutics
  • i Bio
  • SAB Biotherapeutics
  • Altimmune
  • Ology Bioservices
  • Spero Therapeutics
  • Vaxart

第9章：關於我們

簡介目錄
Product Code: GIS10528

Biodefense Market is anticipated to expand from $17.5 billion in 2024 to $35.1 billion by 2034, growing at a CAGR of approximately 6.8%. The Biodefense Market encompasses strategies and technologies aimed at protecting populations against biological threats, including infectious diseases and bioterrorism. It involves vaccines, diagnostics, and detection systems to prevent, detect, and respond to biological incidents. Increasing global health threats and government initiatives are propelling advancements in biodefense capabilities, emphasizing rapid response and resilience.

The Biodefense Market is experiencing robust growth, propelled by the rising threat of biological warfare and infectious diseases. The detection segment leads in performance, with advanced diagnostic systems and biosensors being pivotal in early threat identification. Within this segment, rapid diagnostic kits and portable detection devices are gaining prominence due to their efficiency and ease of use. The vaccines segment follows closely, driven by innovations in recombinant and synthetic vaccines, which offer enhanced protection against emerging pathogens. Therapeutics, including antiviral drugs and monoclonal antibodies, are also witnessing significant advancements, reflecting the urgency for effective treatment options. The integration of artificial intelligence and machine learning in biodefense strategies is becoming increasingly relevant, offering predictive insights and streamlined response mechanisms. Investments in research and development are crucial, fostering innovation and ensuring preparedness against potential biological threats. Collaborative efforts between government entities and private sectors are essential in fortifying global biodefense capabilities.

Market Segmentation
TypeVaccines, Therapeutics, Diagnostics, Detection Devices, Surveillance Systems, Decontamination Solutions, Protective Equipment, Information Technology
ProductAnthrax, Smallpox, Botulism, Radiation/Nuclear, Chemical, Ebola, Zika
ServicesConsulting, Training, Support and Maintenance, Managed Services
TechnologySynthetic Biology, Nanotechnology, Genomics, Bioinformatics
ComponentHardware, Software
ApplicationCivilian, Military, Emergency Response
End UserGovernment, Military, Private Sector, Public Health Organizations
FunctionalityDetection, Protection, Prevention, Response, Recovery
EquipmentPersonal Protective Equipment, Detection Equipment, Decontamination Equipment

The Biodefense Market is characterized by a diverse array of market participants, each vying for competitive advantage through strategic pricing and innovative product launches. Companies are increasingly focusing on developing advanced biodefense solutions, driven by heightened global awareness and the need for robust defense mechanisms. The market witnesses a dynamic interplay of established enterprises and emerging startups, all contributing to the evolving landscape. Pricing strategies remain competitive, reflecting the demand for cost-effective yet technologically advanced solutions. New product launches are frequently observed, as companies strive to meet the evolving needs of governments and private sectors alike. Competition in the Biodefense Market is intense, with key players leveraging advanced technologies to gain a competitive edge. Regulatory frameworks across regions significantly influence market dynamics, with stringent guidelines shaping product development and deployment strategies. The market is witnessing increased collaboration between public and private sectors, enhancing innovation and deployment capabilities. North America remains a dominant force, driven by substantial government investments, while Asia-Pacific is emerging as a lucrative market due to increasing biodefense initiatives. The interplay of regulatory influences and competitive benchmarking continues to define market trajectories, offering both challenges and opportunities for growth.

Geographical Overview:

The biodefense market is witnessing robust growth across various regions, each with unique opportunities. North America leads, driven by significant government investments in biodefense infrastructure and advanced research capabilities. The region's focus on national security and public health preparedness further accelerates market expansion. Europe is also experiencing growth, with increased funding for biodefense initiatives and a strong emphasis on collaborative research efforts. The region's stringent regulatory frameworks and focus on innovation enhance its market potential. In the Asia Pacific, rapid economic development and rising awareness of biological threats are propelling market growth. Key countries like China and India are investing heavily in biodefense technologies and infrastructure. Latin America and the Middle East & Africa are emerging as new growth pockets. In Latin America, increased government attention towards biosecurity measures is evident, while the Middle East & Africa are recognizing the strategic importance of biodefense in ensuring regional stability and security.

The biodefense market is increasingly influenced by global tariffs, geopolitical tensions, and evolving supply chain dynamics. Japan and South Korea are enhancing their biodefense capabilities through innovation and partnerships, mitigating tariff impacts by diversifying suppliers. China is accelerating its domestic biodefense technologies, driven by export restrictions and geopolitical pressures. Taiwan, while central to global semiconductor supply chains, faces vulnerabilities due to regional tensions. The parent market, encompassing public health and security sectors, is witnessing robust growth, propelled by heightened global health threats. By 2035, the market is expected to be characterized by strategic collaborations and technological advancements. Middle East conflicts exacerbate supply chain disruptions and energy price volatility, influencing operational costs and strategic planning in the biodefense sector.

Key Trends and Drivers:

The Biodefense Market is experiencing robust growth, propelled by rising concerns over biological threats and pandemics. Key trends include increased government investments in biodefense infrastructure and research. Nations are prioritizing the development of rapid diagnostic tools and vaccines to counter bioterrorism and infectious disease outbreaks. This trend is further supported by collaborations between public and private sectors to enhance preparedness and response capabilities. Drivers of the market include technological advancements in pathogen detection and identification. The integration of artificial intelligence and machine learning in biodefense systems is improving threat detection accuracy and speed. Additionally, the growing emphasis on biosecurity measures in healthcare and agriculture is fostering market expansion. The demand for advanced biodefense solutions is further fueled by the need for robust surveillance systems to monitor and mitigate biological threats globally. Opportunities abound in the development of portable and cost-effective diagnostic tools, particularly in emerging economies. Companies investing in innovative biotechnology solutions are well-positioned to capture significant market share. The focus on developing next-generation vaccines and therapeutics offers lucrative prospects for growth. As global awareness of biological risks intensifies, the Biodefense Market is poised for continued expansion, driven by technological innovation and strategic partnerships.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Equipment

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Vaccines
    • 4.1.2 Therapeutics
    • 4.1.3 Diagnostics
    • 4.1.4 Detection Devices
    • 4.1.5 Surveillance Systems
    • 4.1.6 Decontamination Solutions
    • 4.1.7 Protective Equipment
    • 4.1.8 Information Technology
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Anthrax
    • 4.2.2 Smallpox
    • 4.2.3 Botulism
    • 4.2.4 Radiation/Nuclear
    • 4.2.5 Chemical
    • 4.2.6 Ebola
    • 4.2.7 Zika
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consulting
    • 4.3.2 Training
    • 4.3.3 Support and Maintenance
    • 4.3.4 Managed Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Synthetic Biology
    • 4.4.2 Nanotechnology
    • 4.4.3 Genomics
    • 4.4.4 Bioinformatics
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Hardware
    • 4.5.2 Software
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Civilian
    • 4.6.2 Military
    • 4.6.3 Emergency Response
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Government
    • 4.7.2 Military
    • 4.7.3 Private Sector
    • 4.7.4 Public Health Organizations
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Detection
    • 4.8.2 Protection
    • 4.8.3 Prevention
    • 4.8.4 Response
    • 4.8.5 Recovery
  • 4.9 Market Size & Forecast by Equipment (2020-2035)
    • 4.9.1 Personal Protective Equipment
    • 4.9.2 Detection Equipment
    • 4.9.3 Decontamination Equipment

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Functionality
      • 5.2.1.9 Equipment
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Functionality
      • 5.2.2.9 Equipment
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Functionality
      • 5.2.3.9 Equipment
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Functionality
      • 5.3.1.9 Equipment
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Functionality
      • 5.3.2.9 Equipment
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Functionality
      • 5.3.3.9 Equipment
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Functionality
      • 5.4.1.9 Equipment
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Functionality
      • 5.4.2.9 Equipment
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Functionality
      • 5.4.3.9 Equipment
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Functionality
      • 5.4.4.9 Equipment
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Functionality
      • 5.4.5.9 Equipment
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Functionality
      • 5.4.6.9 Equipment
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Functionality
      • 5.4.7.9 Equipment
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Functionality
      • 5.5.1.9 Equipment
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Functionality
      • 5.5.2.9 Equipment
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Functionality
      • 5.5.3.9 Equipment
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Functionality
      • 5.5.4.9 Equipment
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Functionality
      • 5.5.5.9 Equipment
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Functionality
      • 5.5.6.9 Equipment
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Functionality
      • 5.6.1.9 Equipment
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Functionality
      • 5.6.2.9 Equipment
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Functionality
      • 5.6.3.9 Equipment
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Functionality
      • 5.6.4.9 Equipment
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Functionality
      • 5.6.5.9 Equipment

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Emergent Bio Solutions
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Bavarian Nordic
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Dyn Port Vaccine Company
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 SIGA Technologies
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Elusys Therapeutics
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Soligenix
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Pharm Athene
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Cangene Corporation
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Alnylam Pharmaceuticals
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Bio Factura
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Achaogen
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Inovio Pharmaceuticals
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Chimerix
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Nanotherapeutics
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 i Bio
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 SAB Biotherapeutics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Altimmune
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Ology Bioservices
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Spero Therapeutics
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Vaxart
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us